Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Australia Medical cannabis prescriptions reach an all-time high ...
  • Czech Republic President signs proposal to regulate hemp extracts with HHC and THC ...
  • Europe EUDA study shows concern over semi-synthetic cannabinoids ...
  • Costa Rica Pharmacies to start medical cannabis sales in January 2025 ...
  • Georgia Department of Agriculture to amend and adopt hemp product rules ...
  • France Deputies propose to tax CBD-containing products ...
  • Arkansas - United States Supreme Court rejects medical cannabis amendment ...
  • Germany Medical cannabis authorisation amendment published in gazette ...
  • India Pilot project launched to explore cannabis cultivation ...
  • Panama Medical cannabis law could be put into practice in coming weeks ...
  • Thailand FDA releases details on proposed cannabis regulation ...
  • India Expert committee formed to tackle cannabis growth ...
View all
News analysis

Increase in prescriptions of unlicensed medical cannabis sparks concern in UK

Written by || 26th August 2024 || News analysis | Cannabis – medical | Health and science | Regulation and legislation | GeographiesEurope United Kingdom

Unlicensed medical cannabis prescriptions in the UK private medical sector have increased by nearly 120% between 2022 and 2023, raising concerns in the healthcare industry over prescribers’ practices.

Based on the UK Care Quality Commission (CQC) annual report on “the safer management of controlled drugs”, private medical facilities in the country increasingly prescribe cannabis-based products for medicinal use (CBPMs), which are mostly unlicensed.

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Tiziana Cauli

Senior reporter/health & science editor
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.